检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]北京大学深圳医院药剂科,广东深圳518036 [2]北京大学深圳医院乳腺外科,广东深圳518036
出 处:《吉林医学》2015年第10期1996-1999,共4页Jilin Medical Journal
基 金:深圳市科技计划项目资助课题[课题编号:201103010]
摘 要:目的:评估睾酮(Testosterone)联合芳香化酶抑制剂阿那曲唑及单用睾酮对雄激素受体(Androgen receptor,AR)阳性的乳腺癌细胞MDA-MB-231(ER-/AR+)作用的效果。方法:配置不同浓度的药物,CCK-8检测药物作用不同时间后细胞增殖抑制率,流式细胞凋亡分析试剂盒检测药物对细胞凋亡影响,荧光定量PCR法检测不同浓度药物作用下MDA-MB-231细胞中hsa-miRNA-30e表达情况。结果:体外实验中阿那曲唑单药及低浓度睾酮对MDA-MB-231细胞起到促增殖作用,高浓度睾酮及联合用药组会抑制MDA-MB-231细胞增殖作用,并且联合用药组较睾酮单药组增殖抑制率(P<0.05)及细胞凋亡率高(P<0.01);分析72h后不同药物浓度下hsa-miRNA-30e表达情况后显示,睾酮及联合用药组较阿那曲唑单药组可以明显降低其表达水平(P<0.01)。结论:睾酮联合芳香化酶抑制剂对AR阳性乳腺癌细胞具有较强的抑制作用,并且其作用机制可能通过miRNA调节途径发挥作用。Objective To evaluate the inhibitory effects of testosterone combined with anastrozole on breast cancer cells MDA - MB -231 (ER - / AR + ). Method The different concentrations of drugs containing testosterone,anastrozole and combined drugs had been prepared with dimethyl sulfoxide. Perform CCK -8 and flowed cytometric detection with Annexin V/ PI double dyeing methods to examine the prolifera-tion and apoptosis of cells respectively. The expression of hsa - miRNA -30e under the different concentrations of drugs in 72 h had been de-tected through real - time PCR. Results In vivo experiment testosterone with low concentration and anastrozole promoted proliferation of MDA- MB -231 cells,but testosterone with high concentration and combination drugs could suppress the cells proliferation in 72 h. Testosterone and combination drugs had also significantly reduced the expression levels of hsa - miRNA - 30e than the anastrozole group in 72 h(P ﹤0. 01). Conclusion Testosterone combined with anastrozole have stronger inhibitory effect on AR positive breast cancer cells,and the mecha-nism of drugs action may be connected with regulation of miRNA.
关 键 词:乳腺癌 睾酮 芳香化酶抑制剂 hsa-miRNA-30e
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63